RU2219927C1 - Ancardin-retard as agent with prolonged anti-calcium effect - Google Patents

Ancardin-retard as agent with prolonged anti-calcium effect Download PDF

Info

Publication number
RU2219927C1
RU2219927C1 RU2002131189A RU2002131189A RU2219927C1 RU 2219927 C1 RU2219927 C1 RU 2219927C1 RU 2002131189 A RU2002131189 A RU 2002131189A RU 2002131189 A RU2002131189 A RU 2002131189A RU 2219927 C1 RU2219927 C1 RU 2219927C1
Authority
RU
Russia
Prior art keywords
agent
ancardin
retard
effect
diumancal
Prior art date
Application number
RU2002131189A
Other languages
Russian (ru)
Other versions
RU2002131189A (en
Inventor
Азад Зияд Оглы Абышев
Эльсевер Мамед Оглы Агаев
Original Assignee
Азад Зияд Оглы Абышев
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Азад Зияд Оглы Абышев filed Critical Азад Зияд Оглы Абышев
Priority to RU2002131189A priority Critical patent/RU2219927C1/en
Application granted granted Critical
Publication of RU2219927C1 publication Critical patent/RU2219927C1/en
Publication of RU2002131189A publication Critical patent/RU2002131189A/en

Links

Images

Abstract

FIELD: medicine, pharmacy. SUBSTANCE: invention relates to an anti-calcium agent with prolonged effect. Agent comprises as an active component the compound 7,7'-ethylenedioxybenzopyrane-2,2'-dione (diumancal) in the dose 0.02 g as a solid-dispersed system with polyethylene glycol with molecular mass 1 500 Da and this agent has the name "Ancardin-retard". Invention provides the maintenance of diumancal activity for 26 h as compared with 2 h period for the early known agent. EFFECT: enhanced effectiveness of agent. 5 tbl, 5 ex

Description

Текст описания в факсимильном виде (см. графическую часть). Description text in facsimile form (see graphic part).

Claims (1)

Средство пролонгированного антикальциевого действия, отличающееся тем, что оно представляет собой таблетку средней массой 0,16 г, содержащую в качестве активного ингредиента 7,7'-этилендиоксибензопиран-2,2'-диона в количестве 0,02 г в виде твердодисперсной системы с полиэтиленгликолем молекулярной массой 1500.A means of prolonged anticalcium action, characterized in that it is a tablet with an average weight of 0.16 g, containing as active ingredient 7,7'-ethylenedioxybenzopyran-2,2'-dione in an amount of 0.02 g in the form of a solid dispersion system with polyethylene glycol molecular weight of 1500.
RU2002131189A 2002-11-21 2002-11-21 Ancardin-retard as agent with prolonged anti-calcium effect RU2219927C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002131189A RU2219927C1 (en) 2002-11-21 2002-11-21 Ancardin-retard as agent with prolonged anti-calcium effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002131189A RU2219927C1 (en) 2002-11-21 2002-11-21 Ancardin-retard as agent with prolonged anti-calcium effect

Publications (2)

Publication Number Publication Date
RU2219927C1 true RU2219927C1 (en) 2003-12-27
RU2002131189A RU2002131189A (en) 2004-06-10

Family

ID=32067159

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002131189A RU2219927C1 (en) 2002-11-21 2002-11-21 Ancardin-retard as agent with prolonged anti-calcium effect

Country Status (1)

Country Link
RU (1) RU2219927C1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2671983C1 (en) * 2018-05-07 2018-11-08 Общество С Ограниченной Ответственностью "Сир" Anticoagulant agent of indirect action on basis of diumancal
RU2678969C1 (en) * 2018-03-28 2019-02-05 Общество С Ограниченной Ответственностью "Сир" Antiarrhythmic drug based on hybrid molecules of amlodipine with (7-methoxicumarin-4-yl)acetic acid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2678969C1 (en) * 2018-03-28 2019-02-05 Общество С Ограниченной Ответственностью "Сир" Antiarrhythmic drug based on hybrid molecules of amlodipine with (7-methoxicumarin-4-yl)acetic acid
RU2671983C1 (en) * 2018-05-07 2018-11-08 Общество С Ограниченной Ответственностью "Сир" Anticoagulant agent of indirect action on basis of diumancal
RU2671983C9 (en) * 2018-05-07 2019-01-24 Общество С Ограниченной Ответственностью "Сир" Anticoagulant agent of indirect action on basis of diumancal

Similar Documents

Publication Publication Date Title
DK1183014T3 (en) Flavored controlled release oral pharmaceutical compositions
DE60019693D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE ABSORPTION-CONNECTING COMPOUNDS
DE69926386D1 (en) PROPOFOL FORMULATION
SE0003449D0 (en) Anticancer compositions
BR9611802A (en) Pharmaceutical compositions
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
DE69727922D1 (en) QUICKLY DECOMPOSING ORAL DOSAGE FORM
BG66093B1 (en) Controlled release compositions comprising nimesulide
PT1207756E (en) USE OF ESPINOSADE OR A FORMULATION THAT INCLUDES ESPINOSADE
DE69940557D1 (en) A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER
DK1007006T3 (en) Formulation of the cefadroxil monohydrate tablet
SE9704401D0 (en) Matrix pellets for greasy, oily or sticky drug substances
FR2878158B1 (en) ORAL PHARMACEUTICAL FORM, SOLID MICROPARTICULAR DESIGNED TO PREVENT MEASUREMENT
FR2771292B1 (en) TIAGABINE-CONTAINING SPHEROIDS, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS
ATE290854T1 (en) CARBAMAZEPINE SUPPORTED-RELEASE FORMULATION
RU2219927C1 (en) Ancardin-retard as agent with prolonged anti-calcium effect
KR970706802A (en) LOW-PRESSURE TABLETED EFFER VESCENT PREPARATION
FR2793685B1 (en) PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION OF PHLOROGLUCINOL AND THEIR PREPARATION
DE60319983D1 (en) Universal composition for controlled release of active ingredient containing chitosan
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
EA200701525A1 (en) PHARMACEUTICAL POLYMERIC COMPOSITION FOR ORAL ADMINISTRATION OF TERBUTALINE SULFATE WITH CONTROLLED DELIVERY
RU2002131189A (en) ANCARDIN-RETARD-MEDICINE OF LONG-TERM ANTI-Calcium ACTION
DK1275383T3 (en) "Modified release" pharmaceutical composition containing Bupropion HCl as active substance
FR2751967B1 (en) ANTI-MALARIA AND ANTIBABESIOSIS AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM